Trial intelligence / Profile preview

Incidence, risk factors and management of chemotherapy hypersensitivity in pediatric malignancies from a tertiary care center in Thailand

TCTR20200607001Completed

Sponsor
N/A
Start
Jul 2019
Countries
1
01

Overview

Trial in cancer, sponsored by N/A. Primary endpoints: Incidence of chemotherapy hypersensitivity reactions and Risk factors for chemotherapy hypersensitivity. Started Jul 2019; status: completed.

02

Conditions

cancer

Beyond the preview

Go deeper on TCTR20200607001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200607001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call